← FDA Drug Approvals (Drugs@FDA)
BYSTOLIC
NDA · New Drug Application · Sponsor: ALLERGAN · Approved 2007-12-17
Drug application
- FDA Application #
NDA021742- Application type
- New Drug Application
- Brand name
- BYSTOLIC
- Generic name
- NEBIVOLOL HYDROCHLORIDE
- Active ingredients
- NEBIVOLOL HYDROCHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- ALLERGAN
- Manufacturer
- Allergan, Inc.
- First approval
- 2007-12-17
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown